in support of the campaign, “One of the SEC key strategic goals is to encourage people to save and invest in the capital market for their good financial health and long-term financial goals. We are of
Period As Of Details HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 HEALTH
Period As Of Details HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Company Q3 30/09/2022 HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Consolidated Q3 30/09/2022 HEALTH
Derivative Warrants | ALIHEA41C2601A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN JANUARY 2026
Derivative Warrants | ALIHEA41C2502A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN FEBRUARY 2025
Derivative Warrants | ALIHEA28C2409A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN SEPTEMBER 2024
Derivative Warrants | ALIHEA41C2410A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN OCTOBER 2024
Derivative Warrants | ALIHEA41C2310A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN OCTOBER 2023
Derivative Warrants | ALIHEA28C2402A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN FEBRUARY 2024
Derivative Warrants | ALIHEA28C2310A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN OCTOBER 2023